SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
Autorzy:
Wellens J; Translational Gastro-Intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.; Translational Research for Gastrointestinal Diseases, University Hospitals Leuven, Leuven, Belgium. Colombel JF; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Satsangi JJ; Translational Gastro-Intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK. Wong SY; Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel disease.
Autorzy:
Chapman TP; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK. Frias Gomes C; Surgical Department, Gastroenterology Division, Hospital Beatriz Ângelo, Loures, Portugal. Louis E; Department of Gastroenterology, CHU Liège University Hospital, Liège, Belgium. Colombel JF; The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. Satsangi J; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
Autorzy:
Hanauer SB; Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Sandborn WJ; University of California San Diego, La Jolla, CA USA. Feagan BG; Robarts Clinical Trials, Western University, London, ON, Canada. Gasink C; Janssen Scientific Affairs, LLC, Horsham, PA, USA. Jacobstein D; Janssen Research & Development, LLC, Spring House, PA, USA. Zou B; Janssen Research & Development, LLC, Spring House, PA, USA. Johanns J; Janssen Research & Development, LLC, Spring House, PA, USA. Adedokun OJ; Janssen Research & Development, LLC, Spring House, PA, USA. Sands BE; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Rutgeerts P; University Hospital, Gasthuisberg, Leuven, Belgium. de Villiers WJS; Stellenbosch University, Stellenbosch, South Africa. Colombel JF; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Ghosh S; NIHR Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
Autorzy:
Feagan BG; Robarts Research Institute, University of Western Ontario, London, ON, Canada. Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA. Colombel JF; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Byrne SO; Takeda Pharmaceuticals International AG, Zurich, Switzerland. Khalid JM; Takeda International - UK Branch, London, UK. Kempf C; Takeda Pharmaceuticals International AG, Zurich, Switzerland. Geransar P; Takeda Pharmaceuticals International AG, Zurich, Switzerland. Bhayat F; Takeda Pharmaceuticals International Co., Cambridge, MA, USA. Rubin DT; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.
Autorzy:
Rosario M; Clinical Pharmacology Department, Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA. French JL; Metrum Research Group LLC, Tariffville, CT, USA. Dirks NL; Metrum Research Group LLC, Tariffville, CT, USA. Sankoh S; Clinical Pharmacology Department, Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA. Parikh A; Clinical Pharmacology Department, Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA. Yang H; Clinical Pharmacology Department, Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA. Danese S; Inflammatory Bowel Disease Clinical and Research Unit, Istituto Clinico Humanitas, Milan, Italy. Colombel JF; Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA. Smyth M; Takeda Development Centre Europe Ltd, London, UK. Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA. Feagan BG; Robarts Research Institute, University of Western Ontario, London, ON, Canada. Reinisch W; Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, and Department of Internal Medicine, McMaster University, Hamilton, ON, Canada. Sands BE; Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA. Sans M; Digestive Diseases Service, Centro Médico Teknon, Barcelona, Spain. Fox I; Clinical Pharmacology Department, Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.
Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study.
Autorzy:
Sandborn WJ; Inflammatory Bowel Disease Center, University of California San Diego, La Jolla, CA, USA. Rutgeerts P; Department of Gastroenterology, Catholic University Leuven, Belgium. Colombel JF; Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Ghosh S; Division of Gastroenterology, University of Calgary, Calgary, AB, Canada. Petryka R; NZOZ Vivamed, Zespól Lekarzy Specjalistów, Warszawa, Poland. Sands BE; Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Mitra P; Bristol-Myers Squibb, Lawrenceville, NJ, USA. Luo A; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial.
Autorzy:
Reinisch W; Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, ON, Canada; and Department of Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria. Colombel JF; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. D'Haens G; Department of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands; and Imelda GI Clinical Research Center, Bonheiden, Belgium. Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA. Rutgeerts P; Division of Gastroenterology, Department of Internal Medicine, University of Leuven, Leuven, Belgium. Geboes K; Department of Pathology, University of Leuven, Leuven, Belgium. Petersson J; Global Medical Affairs Gastroenterology, AbbVie Inc., North Chicago, IL, USA. Eichner S; Global Medical Affairs Gastroenterology, AbbVie Inc., North Chicago, IL, USA. Zhou Q; Data and Statistical Sciences, AbbVie Inc., North Chicago, IL, USA. Robinson AM; Global Medical Affairs Gastroenterology, AbbVie Inc., North Chicago, IL, USA. Read HA; Global Medical Affairs Gastroenterology, AbbVie Inc., North Chicago, IL, USA. Thakkar R; Global Medical Affairs Gastroenterology, AbbVie Inc., North Chicago, IL, USA.
Long-term Efficacy of Vedolizumab for Crohn's Disease.
Autorzy:
Vermeire S; University Hospitals Leuven, Belgium. Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. Colombel JF; Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York, USA. Feagan BG; Robarts Clinical Trials, Robarts Research Institute, University of Western Ontario, London, Ontario, Canada. Sandborn WJ; University of California San Diego and UC San Diego Health System, La Jolla, California, USA. Sands BE; Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York, USA. Danese S; Istituto Clinico Humanitas, Milan, Italy. D'Haens GR; Academic Medical Center, Amsterdam, The Netherlands. Kaser A; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Panaccione R; Inflammatory Bowel Disease Clinic, University of Calgary, Calgary, Alberta, Canada. Rubin DT; University of Chicago Inflammatory Bowel Disease Center, Chicago, Illinois, USA. Shafran I; Shafran Gastroenterology Center, Winter Park, Florida, USA. McAuliffe M; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USA. Kaviya A; Takeda Development Centre Europe Ltd, London, UK. Sankoh S; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USA. Mody R; Takeda Pharmaceuticals International, Inc., Deerfield, Illinois, USA. Abhyankar B; Takeda Development Centre Europe Ltd, London, UK. Smyth M; Takeda Development Centre Europe Ltd, London, UK.
Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.
Autorzy:
Collins M; Gastroenterology and Hepatology Department, Lille University Hospital, Lille, France.; Gastroenterology Department, Kremlin-Bicêtre University Hospital, Le Kremlin-Bicêtre, France. Sarter H; Lille Inflammation Research International Center, Université Lille, CHRU de Lille, France. Gower-Rousseau C; Lille Inflammation Research International Center, Université Lille, CHRU de Lille, France. Koriche D; Colorectal Surgery Department, Lille University Hospital, Lille, France. Libier L; Gastroenterology and Hepatology Department, Lille University Hospital, Lille, France. Nachury M; Gastroenterology and Hepatology Department, Lille University Hospital, Lille, France. Cortot A; Gastroenterology and Hepatology Department, Lille University Hospital, Lille, France. Zerbib P; Colorectal Surgery Department, Lille University Hospital, Lille, France. Blanc P; Gastroenterology and Hepatology Department, Montpellier University Hospital, Montpellier, France. Desreumaux P; Gastroenterology and Hepatology Department, Lille University Hospital, Lille, France.; Lille Inflammation Research International Center, Université Lille, CHRU de Lille, France. Colombel JF; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Peyrin-Biroulet L; Gastroenterology Department, Nancy University Hospital, Lorraine University, Vandoeuvre, France. Pineton de Chambrun G; Gastroenterology and Hepatology Department, Lille University Hospital, Lille, France.; Gastroenterology and Hepatology Department, Montpellier University Hospital, Montpellier, France.
Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's Disease.
Autorzy:
Marteau P; Service d'Hépatogastroentérologie, Hôpital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris cedex, France Denis Diderot - Paris7 University, Paris, France. Laharie D; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie - Université Bordeaux, Laboratoire de bactériologie, F-33000 Bordeaux, Pessac, France . Colombel JF; CHRU de Lille, Hôpital Claude Huriez, Service des Maladies de l'Appareil Digestif -Endoscopie Digestive, Lille, France Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Martin L; Service d'Hépatogastroentérologie, Hôpital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris cedex, France. Coevoet H; CHRU de Lille, Hôpital Claude Huriez, Service des Maladies de l'Appareil Digestif -Endoscopie Digestive, Lille, France. Allez M; Department of Hepatogastroenterology, Hôpital Saint-Louis, Paris, France. Cadiot G; Department of Hepato-Gastroenterology and Digestive Oncology, Hôpital Robert Debré, Boulevard du Général Koenig, 51100 Reims Cedex, France. Bourreille A; CHU de Nantes, Hôtel-Dieu, Hépato-Gastroentérologie, Institut des Maladies de l'Appareil Digestif, F-44093 Nantes, France. Carbonnel F; Department of Gastroenterology, Assistance Publique-Hôpitaux de Paris (AP-HP), University Hospitals Paris-Sud, Site de Bicêtre, Paris Sud University, Paris XI, Le Kremlin Bicêtre, Villejuif, France. Bouhnik Y; Hôpital Beaujon, Gastroentérologie, Maladies Inflammatoires Chroniques de l'Intestin et Assistance Nutritive, APHP- Université Paris Diderot Paris 7, Clichy, France. Coffin B; Hôpital Louis Mourier, service d'Hépato-Gastroentérologie, Pôle Maladie Appareil Digestif, APHP - Université Paris VII, F-92700 Colombes, France. Duclos B; Service d'Hépato-Gastroentérologie et Assistance Nutritive, CHU Strasbourg, Strasbourg, France. Dupas JL; Service d'Hépato- Gastroentérologie, CHU Amiens, Université de Picardie Jules Verne, Amiens, France. Moreau J; CHU de Toulouse, Hôpital Rangueil, Service de Gastro-entérologie et Nutrition, F-31059 Toulouse, France. Louis E; Centre Hospitalier, Universitaire de Liège, Liège, Belgium. Mary JY; Inserm UMR 1153, Equipe Epidemiologie Clinique, Statistique pour la Recherche en Santé, Hôpital Saint-Louis, Université Paris Diderot - Paris 7, Paris, France.
Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review.
Autorzy:
Katsanos KH; Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Roda G; Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Brygo A; Department of Stomatology, Centre Hospitalier Régional Universitaire de Lille, Lille, France. Delaporte E; Department of Dermatology, Centre Hospitalier Régional Universitaire de Lille, Lille, France. Colombel JF; Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA jean-frederic.colombel@mssm.edu.
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2015 Nov; Vol. 9 (11), pp. 1043-52. Date of Electronic Publication: 2015 Jul 10.
High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy.
Autorzy:
Hendler SA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Cohen BL; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Sands BE; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Mayer L; Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Agarwal S; Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2015 Mar; Vol. 9 (3), pp. 266-75. Date of Electronic Publication: 2014 Dec 24.
Typ publikacji:
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
